TrialJournal of acquired immune deficiency syndromes (1999)2012

Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals.

Mathias Lichterfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.